TOVX icon

Theriva Biologics
TOVX

Overview Fund Activity

27 hedge funds and large institutions have $836K invested in Theriva Biologics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 0 closing their positions.

Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
3
Closed
–
Calls
$2.37M
Puts
–
Net Calls
+$2.37M
Net Calls Change
-$503K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$228K
2
Goldman Sachs
2
Goldman Sachs
New York
$30K
3
SCA
3
Snowden Capital Advisors
New York
$21K
4
UBS Group
4
UBS Group
Switzerland
$12K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$11K

Top Sellers

1
SM
1
Sabby Management
Florida
$379K
2
William Blair & Company
2
William Blair & Company
Illinois
$24K
3
BNP Paribas Financial Markets
3
BNP Paribas Financial Markets
France
$0
Name Market Value Shares Shares
Change 		Shares
Change %
BNP Paribas Financial Markets
26
BNP Paribas Financial Markets
France
$0 1 – –
FHA
27
Flagship Harbor Advisors
Massachusetts
$0 15 – –
AG
28
Advisor Group
Arizona
$0 421 – –
Wells Fargo
29
Wells Fargo
California
$0 16 +1 +7%
SFS
30
Sowell Financial Services
Arkansas
$0 74 +74 –
1
2